Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy
Clinical trial NCT03616834 · COMPLETED
Trial details
- NCT number
- NCT03616834
- Sponsor
- Effector Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2021-01-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.